-+ 0.00%
-+ 0.00%
-+ 0.00%

Prenetics FY25 net loss narrows 19.73% to $39.98 million; revenue jumps to $92.39 million

PUBT·04/30/2026 14:21:14
Listen to the news
Prenetics FY25 net loss narrows 19.73% to $39.98 million; revenue jumps to $92.39 million
  • Prenetics posted a net loss of USD 39.98 million for fiscal year 2025, narrowing from the prior year.
  • Revenue jumped to USD 92.39 million, up 480%.
  • Adjusted EBITDA loss improved to USD 13.91 million.
  • Consumer Health segment climbed to USD 79.45 million, driven by IM8 revenue of USD 60.1 million in its first full fiscal year.
  • Gross margin from continuing operations slipped to 53% due to the inclusion of lower-margin Europa, with Prenetics expecting gross margin to improve to over 60% in 2026 following Europa divestiture.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prenetics Global Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-028623), on April 30, 2026, and is solely responsible for the information contained therein.